Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

1. Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder)

Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder) SHTG Assessment | 1 SHTG Assessment 01-21 January 2021 Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder) What were we asked to look at? NHS Education for Scotland (NES) asked us to review the published evidence on the effectiveness (...) of remote digital psychotherapy for adult patients with depression or anxiety (including post-traumatic stress disorder), compared with face-to-face therapy. Remote digital psychotherapy can be delivered via telephone, the internet, video, or online messaging. Our assessment included whether clinical staff can build an effective therapeutic relationship with clients during psychotherapy via digital media. We also assessed the literature relating to patient satisfaction and acceptability of remote

2021 SHTG Advice Statements

2. Clinician-guided internet-based psychotherapy compared with face-to-face therapy for people with anxiety or depression

Clinician-guided internet-based psychotherapy compared with face-to-face therapy for people with anxiety or depression SHTG Assessment | 1 SHTG Assessment 02-21 January 2021 Clinician-guided internet-based psychotherapy compared with face-to-face therapy for people with anxiety or depression What were we asked to look at? NHS Education for Scotland (NES) asked us to review the published evidence on the effectiveness, cost-effectiveness, safety and acceptability of clinician-guided internet (...) -based psychotherapeutic interventions compared with in-person, face-to-face individual or group psychotherapeutic interventions for adult patients with depression or anxiety disorders. Why is this important? This report will support an update of the NES matrix of psychological therapies commissioned in NHS Scotland. Depression and anxiety disorders are common and it is likely that there have been rapid advances in interactive technologies and changes in digital skills in society since the NES Matrix

2021 SHTG Advice Statements

3. Treatment-resistant depression: avoid esketamine (Spravato)

Treatment-resistant depression: avoid esketamine (Spravato) Prescrire IN ENGLISH - Spotlight ''Treatment-resistant depression: avoid esketamine (Spravato°)'', 1 January 2021 {1} {1} {1} | | > > > Treatment-resistant depression: avoid esketamine (Spravato°) Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Treatment-resistant depression: avoid (...) esketamine (Spravato°) Esketamine nasal spray (Spravato°) has been authorised for use in so-called "treatment-resistant" depression. Its efficacy is uncertain, and its harm-benefit balance is unfavourable due to serious adverse effects including neuropsychiatric and cardiac disorders. The various options available to treat depression usually have moderate efficacy at best. Antidepressants are commonly used. The options available when the response to an antidepressant is considered inadequate

2021 Prescrire

4. Space from Depression for treating adults with depression (IEPR)

Space from Depression for treating adults with depression (IEPR) Overview | Space from Depression for treating adults with depression | Advice | NICE Space from Depression for treating adults with depression Medtech innovation briefing [MIB215] Published date: 07 May 2020 Advice NICE has developed an Improving Access to Psychological Therapies (IAPT) report on Space from Depression for treating adults with depression. Find out more about the .

2021 National Institute for Health and Clinical Excellence - IAPT

5. Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia

Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia - Repository of AIHTA GmbH English | Browse - - - Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia Gassner, L. and Mayer-Ferbas, J. (2020): Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia (...) , Depression, Insomnia and Schizophrenia. HTA-Projektbericht 133. Preview - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. , oder 1MB Abstract Introduction: Music therapy is an expression promoting, scientific-artistic-creative and independent form of treatment and aims at maintaining, restoring, and furthering physical, emotional, and mental health. This systematic review aims at assessing the effectiveness of music therapy for the treatment of autism spectrum disorder, dementia

2020 Austrian Institute of Health Technology Assessment

6. Depression: cardiac risks with citalopram (Seropram and other brands), even greater if combined with omeprazole (Mopral and other brands)

Depression: cardiac risks with citalopram (Seropram and other brands), even greater if combined with omeprazole (Mopral and other brands) Prescrire IN ENGLISH - Spotlight ''Depression: cardiac risks with citalopram (Seropram° and other brands), even greater if combined with omeprazole (Mopral° and other brands)'', 1 December 2020 {1} {1} {1} | | > > > Depression: cardiac risks with citalopram (Seropram° and other brands), even greater if combined with omeprazole (Mopral° and other brands (...) ) Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Depression: cardiac risks with citalopram (Seropram° and other brands), even greater if combined with omeprazole (Mopral° and other brands) Citalopram (Seropram° and other brands), an antidepressant, carries a risk of cardiac rhythm disorders and sudden death, all the more so when combined with omeprazole

2020 Prescrire

7. Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression

Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression Research White Paper Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Report on Registry Configuration Research White Paper Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Report on Registry Configuration Prepared for: Agency for Healthcare Research and Quality U.S (...) was based on a Research White Paper, Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression, by OM1, Inc., with subcontractors the American Board of Family Medicine and American Psychiatric Association through the Agency for Healthcare Research and Quality (AHRQ). Suggested citation: Leavy MB, Cooke D, Hajjar S, Bickelman E, Egan B, Clarke D, Gibson D, Casanova B, Gliklich R. Outcome Measure Harmonization and Data Infrastructure for Patient- Centered

2020 Effective Health Care Program (AHRQ)

8. Effects of bilateral transcranial direct current stimulation on working memory and global cognition in older patients with remitted major depression: A pilot randomized clinical trial Full Text available with Trip Pro

Effects of bilateral transcranial direct current stimulation on working memory and global cognition in older patients with remitted major depression: A pilot randomized clinical trial Effects of bilateral transcranial direct current stimulation on working memory and global cognition in older patients with remitted major depression: A pilot randomized clinical trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard (...) Share Permalink Copy Page navigation Int J Geriatr Psychiatry Actions . 2020 Jun 11. doi: 10.1002/gps.5361. Online ahead of print. Effects of bilateral transcranial direct current stimulation on working memory and global cognition in older patients with remitted major depression: A pilot randomized clinical trial , , , , , , , , , Affiliations Expand Affiliations 1 Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 2 Department of Psychiatry, University

2020 EvidenceUpdates

9. Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial

Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several (...) navigation Int Psychogeriatr Actions . 2020 Mar 5;1-15. doi: 10.1017/S1041610220000216. Online ahead of print. Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial , , , , , Affiliations Expand Affiliations 1 Department of Old Age Psychiatry, Oslo University Hospital, Gaustad, Postbox 4956, Nydalen, 0424Oslo, Norway. 2 Norwegian Health Association, Postbox 7139 Majorstuen, 0207Oslo, Norway

2020 EvidenceUpdates

10. Treatment for depression comorbid with dementia

Treatment for depression comorbid with dementia Treatment for depression comorbid with dementia | Evidence-Based Mental Health Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here (...) Treatment for depression comorbid with dementia Article Text Clinical review Treatment for depression comorbid with dementia Nina Baruch , Jennifer Burgess , , Manjunadh Pillai , Charlotte Louise Allan , Statistics from Altmetric.com Footnotes Contributors CLA planned the article; NB, JB and MP made substantial contributions to the first draft. The first draft was prepared by CLA and all authors approved the final version. Funding The authors have not declared a specific grant for this research from any

2020 Evidence-Based Mental Health

11. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study

Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) : 10.1176/appi.ajp.2020.19080844. Online ahead of print. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliation 1 Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (Dichtel, Kimball, Miller); Depression Clinical and Research Program, Department of Psychiatry

2020 EvidenceUpdates

12. Reducing the Risk for Postpartum Depression in Adolescent Mothers: A Randomized Controlled Trial

Reducing the Risk for Postpartum Depression in Adolescent Mothers: A Randomized Controlled Trial Reducing the Risk for Postpartum Depression in Adolescent Mothers: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Obstet Gynecol Actions . 2020 Sep;136(3):613-621. doi: 10.1097/AOG.0000000000004003. Reducing the Risk for Postpartum Depression in Adolescent Mothers

2020 EvidenceUpdates

13. Esketamine (Spravato) - In combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin–norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant major depressive disorder, who have not responded to at least two differ

Esketamine (Spravato) - In combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin–norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant major depressive disorder, who have not responded to at least two differ 1 Published 7 September 2020 SMC2258 esketamine 28mg nasal spray, solution (Spravato®) Janssen-Cilag Ltd 7 August 2020 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area (...) Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland. The advice is summarised as follows: ADVICE: following a full submission esketamine (Spravato®) is accepted for use within NHSScotland. Indication under review: In combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants

2020 Scottish Medicines Consortium

14. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial. (Abstract)

Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial. Mental health comorbidities are increasing worldwide and worsen outcomes for people with diabetes, especially when care is fragmented.To assess whether collaborative care vs usual care lowers depressive symptoms and improves cardiometabolic indices among adults with diabetes (...) of patients at 24 months who had at least a 50% reduction in Symptom Checklist Depression Scale (SCL-20) scores (range, 0-4; higher scores indicate worse symptoms) and a reduction of at least 0.5 percentage points in HbA1c, 5 mm Hg in SBP, or 10 mg/dL in LDL cholesterol. Prespecified secondary outcomes were percentage of patients at 12 and 24 months who met treatment targets (HbA1c <7.0%, SBP <130 mm Hg, LDL cholesterol <100 mg/dL [<70 mg/dL if prior cardiovascular disease]) or had improvements

2020 JAMA

15. Behavioural activation therapy for depression in adults with non-communicable diseases. (Abstract)

Behavioural activation therapy for depression in adults with non-communicable diseases. Depression is common in people with non-communicable diseases (NCDs) such as cardiovascular disease, diabetes, cancer, and chronic respiratory conditions. The co-existence of depression and NCDs may affect health behaviours, compliance with treatment, physiological factors, and quality of life. This in turn is associated with worse outcomes for both conditions. Behavioural activation is not currently (...) indicated for the treatment of depression in this population in the UK, but is increasingly being used to treat depression in adults.To examine the effects of behavioural activation compared with any control group for the treatment of depression in adults with NCDs. To examine the effects of behavioural activation compared with each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment

2020 Cochrane

16. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. (Abstract)

Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. Low levels of 25-hydroxyvitamin D have been associated with higher risk for depression later in life, but there have been few long-term, high-dose large-scale trials.To test the effects of vitamin D3 supplementation on late-life depression risk and mood scores.There were 18 353 men and women aged 50 years or older (...) in the VITAL-DEP (Vitamin D and Omega-3 Trial-Depression Endpoint Prevention) ancillary study to VITAL, a randomized clinical trial of cardiovascular disease and cancer prevention among 25 871 adults in the US. There were 16 657 at risk for incident depression (ie, no depression history) and 1696 at risk for recurrent depression (ie, depression history but no treatment for depression within the past 2 years). Randomization occurred from November 2011 through March 2014; randomized treatment ended

2020 JAMA

17. Implanted vagus nerve stimulation for treatment-resistant depression

Implanted vagus nerve stimulation for treatment-resistant depression Implanted vagus nerve stimulation for treatment-resistant depression Interventional procedures guidance Published: 12 August 2020 www.nice.org.uk/guidance/ipg679 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account (...) Recommendations Recommendations 1.1 Evidence on the safety of implanted vagus nerve stimulation for treatment- resistant depression raises no major safety concerns, but there are frequent, well-recognised side effects. Evidence on its efficacy is limited in quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE website. 1.2 Clinicians wishing to do implanted vagus nerve

2020 National Institute for Health and Clinical Excellence - Interventional Procedures

18. Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings: A Systematic Review and Meta-analysis

Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings: A Systematic Review and Meta-analysis Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings: A Systematic Review and Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete (...) ;e201586. doi: 10.1001/jamapsychiatry.2020.1586. Online ahead of print. Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings: A Systematic Review and Meta-analysis , , , , , , , , Affiliations Expand Affiliations 1 PolicyLab, Center for Pediatric Clinical Effectiveness, Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 2 Department of Pediatrics

2020 EvidenceUpdates

19. Effectiveness of cognitive behavioural therapy for perinatal depression: A systematic review and meta-analysis

Effectiveness of cognitive behavioural therapy for perinatal depression: A systematic review and meta-analysis Effectiveness of cognitive behavioural therapy for perinatal depression: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review J Clin Nurs Actions . 2020 Sep;29(17-18):3170-3182. doi: 10.1111/jocn.15378. Epub 2020 Jul 15. Effectiveness of cognitive behavioural therapy for perinatal depression: A systematic review and meta-analysis

2020 EvidenceUpdates

20. Pharmacological treatment of depression in people with a primary brain tumour. (Abstract)

Pharmacological treatment of depression in people with a primary brain tumour. This is the second updated version of the Cochrane Review published in Issue 3, 2010 and first updated in Issue 5, 2013. People with a primary brain tumour often experience depression, for which drug treatment may be prescribed. However, they are also at high risk of epileptic seizures, cognitive impairment, and fatigue, all of which are potential adverse side effects of antidepressants. The benefit, or harm (...) , of pharmacological treatment of depression in people with a primary brain tumour is unclear.To assess the benefits and harms of pharmacological treatment of depression in people with a primary brain tumour.We updated the search to include CENTRAL, MEDLINE, Embase, and PsycINFO to September 2019. As in the original review, we also handsearched Neuro-Oncology, Journal of Neuro-Oncology, Journal of Neurology, Neurosurgery and Psychiatry, and Journal of Clinical Oncology: for the current update we handsearched

2020 Cochrane